肠道微生物组在塑造免疫受损宿主药物反应中的作用
Semeh Bejaoui1, Federica D'Amico1, Silvia Turroni2
1Unit of Microbiome Science and Biotechnology, Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
肠道微生物群影响药物的疗效和毒性,特别是在接受化疗或移植的免疫功能低下患者中. 了解这些微生物组与药物相互作用是个性化医疗和改善患者治疗结果的关键.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 越来越多的证据将肠道微生物组与免疫受损患者的药物相互作用联系起来.
- 肠道微生物群影响药物的疗效和毒性,具有显著的转化潜力.
研究的目的:
- 审查肠道微生物与药物之间的关系,重点关注免疫受损患者的化疗和免疫治疗.
- 突出肠道微生物群在药物药理动力学和宿主免疫调节中的作用.
主要方法:
- 在PubMed的综合文献搜索到2026年2月.
- 包含相关文章,优先考虑临床研究和作者已知的文献.
主要成果:
- 肠道微生物可以激活/非激活抗癌药物,并调节免疫治疗结果.
- 微生物组会影响移植受体免疫抑制剂的药理动力学.
- 有证据表明,有针对性的微生物组操纵可以改善治疗结果,尽管研究通常很小且异质.
结论:
- 微生物组与药物相互作用对于药理学至关重要,需要精心设计的临床研究和综合模型.
- 先进的计算工具 (AI,机器学习) 可以分析复杂的微生物组数据.
- 识别微生物特征将使个性化策略能够获得更好的临床结果和生存.
更多相关视频
11:003D Flipwell Engineering for Developing Asynchronous Systems for Toxicologic and Immunomodulatory Therapies in Bacterial, Gut, and Immune Cells
Published on: October 17, 2025
10:24Assessing the Viability of a Synthetic Bacterial Consortium on the In Vitro Gut Host-microbe Interface
Published on: July 4, 2018
相关概念视频
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Microorganisms in Medicine and Therapeutics
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
